Controlled & Modified Drug Release
07 May 2014 - 08 May 2014 - Philadelphia University City Hotel, Philadelphia, PA, USA
Controlled & Modified Drug Release continues to be one of the most innovative areas in drug development. Oral modified release drug products account for one third of the drug product market. Successfully getting your modified release drugs to the market place has significant product lifecycle benefits.
Join us in Philadelphia, this May to learn directly from industry's leading experts. Hear unique take-home examples to enhance your product pipeline. Gather insights into the latest technologies and methods in improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry.
Hear from Merck, Novartis, Bristol Myers Squibb, GlaxoSmithKline, Zafgen, Inc, Johnson & Johnson, AstraZeneca, Takeda, Taris Biomedical, Catalent, Sirius Analytical, University of New England, and many more drug delivery and formulation innovators.
Use promo code BROTON to enable a 15% discount off standard registration pricing.
Learn from leading experts to enhance your drug product pipeline. Discover novel technologies and methods in improving drug release mechanisms, maximizing exposure, and reducing time-to-market.